Theranostics Market Size, Share, Trends, Industry Analysis Report: By Product Type, Application, Technology, End User, and Region

Description

List of Tables

The theranostics market size is expected to reach USD 8,640.97 million by 2034, according to a new study by Polaris Market Research. The report "Theranostics Market Size, Share, Trends, Industry Analysis Report: By Product Type (Instruments, Reagents, and Software), Application, Technology, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Theranostics is a medical approach that integrates diagnostics and therapy to provide personalized treatment based on a patient's specific disease characteristics. This method enables precise disease detection, targeted therapy, and real-time monitoring of treatment effectiveness. The theranostics market growth is propelled by the increasing prevalence of cancer and other chronic diseases, advancements in molecular imaging, and the rising adoption of precision medicine.

Theranostics market opportunities lie in the expansion of radiotheranostics, AI-driven diagnostic solutions, and biomarker-based therapies. Key trends include the growing use of companion diagnostics, regulatory support for personalized treatments, and strategic collaborations among pharmaceutical, biotechnology, and diagnostic companies. With continuous innovation and increasing demand for targeted therapies, the market is expected to expand further, particularly in oncology and neurology applications.

Theranostics Market Report Highlights

The theranostics market, based on product type, is segmented into instruments, reagents, and software. Among these, the reagents segment held the largest market share in 2024, primarily due to the critical role they play in diagnostic tests, including biomarker assays and molecular diagnostic applications.
The market, by application, is segmented into oncology, neurology, cardiology, and infectious diseases. The oncology segment dominated the theranostics market share in 2024 due to the increasing prevalence of cancer globally and the growing adoption of targeted therapies for cancer treatment.
The market, by technology, is segmented into genomics, proteomics, metabolomics, and biomarkers. The genomics segment accounted for a major market share in 2024 due to the growing demand for genomic-based diagnostics and targeted therapies.
North America dominated the theranostics market revenue share in 2024, primarily driven by the strong presence of advanced healthcare infrastructure, high adoption of precision medicine, and significant investments in research and development.
The theranostics market comprises several active companies contributing to advancements in personalized medicine. A few notable participants include Advanced Accelerator Applications; Bayer AG; GE HealthCare Technologies Inc.; Siemens Healthineers AG; Cardinal Health, Inc.; Lantheus Holdings, Inc.; Curium Pharma; Abbott Laboratories; Thermo Fisher Scientific Inc.; Astellas Pharma Inc.; F. Hoffmann-La Roche AG; and Illumina, Inc.

Polaris Market Research has segmented the theranostics market report on the basis of product type, application, technology, end user, and region:

By Product Type Outlook (Revenue - USD Million, 2020-2034)

Instruments
Reagents
Software

By Application Outlook (Revenue - USD Million, 2020-2034)

Oncology
Neurology
Cardiology
Infectious Diseases

By Technology Outlook (Revenue - USD Million, 2020-2034)

Genomics
Proteomics
Metabolomics
Biomarkers

By End User Outlook (Revenue - USD Million, 2020-2034)

Hospitals
Diagnostic Laboratories
Research Institutes

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

Product Code: PM1295

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Theranostics Market Insights

4.1. Theranostics Market - Market Snapshot
4.2. Theranostics Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.2. Restraints and Challenges
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Theranostics Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Theranostics Market, by Product Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Theranostics Market, by Product Type, 2020-2034 (USD Million)
5.3. Instruments
- 5.3.1. Global Theranostics Market, by Instruments, by Region, 2020-2034 (USD Million)
5.4. Reagents
- 5.4.1. Global Theranostics Market, by Reagents, by Region, 2020-2034 (USD Million)
5.5. Software
- 5.5.1. Global Theranostics Market, by Software, by Region, 2020-2034 (USD Million)

6. Global Theranostics Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Theranostics Market, by Application, 2020-2034 (USD Million)
6.3. Oncology
- 6.3.1. Global Theranostics Market, by Oncology, by Region, 2020-2034 (USD Million)
6.4. Neurology
- 6.4.1. Global Theranostics Market, by Neurology, by Region, 2020-2034 (USD Million)
6.5. Cardiology
- 6.5.1. Global Theranostics Market, by Cardiology, by Region, 2020-2034 (USD Million)
6.6. Infectious Diseases
- 6.6.1. Global Theranostics Market, by Infectious Diseases, by Region, 2020-2034 (USD Million)

7. Global Theranostics Market, by Technology

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Theranostics Market, by Technology, 2020-2034 (USD Million)
7.3. Genomics
- 7.3.1. Global Theranostics Market, by Genomics, by Region, 2020-2034 (USD Million)
7.4. Proteomics
- 7.4.1. Global Theranostics Market, by Proteomics, by Region, 2020-2034 (USD Million)
7.5. Metabolomics
- 7.5.1. Global Theranostics Market, by Metabolomics, by Region, 2020-2034 (USD Million)
7.6. Biomarkers
- 7.6.1. Global Theranostics Market, by Biomarkers, by Region, 2020-2034 (USD Million)

8. Global Theranostics Market, by End User

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Theranostics Market, by End User, 2020-2034 (USD Million)
8.3. Hospitals
- 8.3.1. Global Theranostics Market, by Hospitals, by Region, 2020-2034 (USD Million)
8.4. Diagnostic Laboratories
- 8.4.1. Global Theranostics Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD Million)
8.5. Research Institutes
- 8.5.1. Global Theranostics Market, by Research Institutes, by Region, 2020-2034 (USD Million)

9. Global Theranostics Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. Theranostics Market Assessment, By Geography, 2020-2034 (USD Million)
9.3. Theranostics Market - North America
- 9.3.1. North America: Theranostics Market, by Product Type, 2020-2034 (USD Million)
- 9.3.2. North America: Theranostics Market, by Application, 2020-2034 (USD Million)
- 9.3.3. North America: Theranostics Market, by Technology, 2020-2034 (USD Million)
- 9.3.4. North America: Theranostics Market, by End User, 2020-2034 (USD Million)
- 9.3.5. Theranostics Market - US
  - 9.3.5.1. US: Theranostics Market, by Product Type, 2020-2034 (USD Million)
  - 9.3.5.2. US: Theranostics Market, by Application, 2020-2034 (USD Million)
  - 9.3.5.3. US: Theranostics Market, by Technology, 2020-2034 (USD Million)
  - 9.3.5.4. US: Theranostics Market, by End User, 2020-2034 (USD Million)
- 9.3.6. Theranostics Market - Canada
  - 9.3.6.1. Canada: Theranostics Market, by Product Type, 2020-2034 (USD Million)
  - 9.3.6.2. Canada: Theranostics Market, by Application, 2020-2034 (USD Million)
  - 9.3.6.3. Canada: Theranostics Market, by Technology, 2020-2034 (USD Million)
  - 9.3.6.4. Canada: Theranostics Market, by End User, 2020-2034 (USD Million)
9.4. Theranostics Market - Europe
- 9.4.1. Europe: Theranostics Market, by Product Type, 2020-2034 (USD Million)
- 9.4.2. Europe: Theranostics Market, by Application, 2020-2034 (USD Million)
- 9.4.3. Europe: Theranostics Market, by Technology, 2020-2034 (USD Million)
- 9.4.4. Europe: Theranostics Market, by End User, 2020-2034 (USD Million)
- 9.4.5. Theranostics Market - UK
  - 9.4.5.1. UK: Theranostics Market, by Product Type, 2020-2034 (USD Million)
  - 9.4.5.2. UK: Theranostics Market, by Application, 2020-2034 (USD Million)
  - 9.4.5.3. UK: Theranostics Market, by Technology, 2020-2034 (USD Million)
  - 9.4.5.4. UK: Theranostics Market, by End User, 2020-2034 (USD Million)
- 9.4.6. Theranostics Market - France
  - 9.4.6.1. France: Theranostics Market, by Product Type, 2020-2034 (USD Million)
  - 9.4.6.2. France: Theranostics Market, by Application, 2020-2034 (USD Million)
  - 9.4.6.3. France: Theranostics Market, by Technology, 2020-2034 (USD Million)
  - 9.4.6.4. France: Theranostics Market, by End User, 2020-2034 (USD Million)
- 9.4.7. Theranostics Market - Germany
  - 9.4.7.1. Germany: Theranostics Market, by Product Type, 2020-2034 (USD Million)
  - 9.4.7.2. Germany: Theranostics Market, by Application, 2020-2034 (USD Million)
  - 9.4.7.3. Germany: Theranostics Market, by Technology, 2020-2034 (USD Million)
  - 9.4.7.4. Germany: Theranostics Market, by End User, 2020-2034 (USD Million)
- 9.4.8. Theranostics Market - Italy
  - 9.4.8.1. Italy: Theranostics Market, by Product Type, 2020-2034 (USD Million)
  - 9.4.8.2. Italy: Theranostics Market, by Application, 2020-2034 (USD Million)
  - 9.4.8.3. Italy: Theranostics Market, by Technology, 2020-2034 (USD Million)
  - 9.4.8.4. Italy: Theranostics Market, by End User, 2020-2034 (USD Million)
- 9.4.9. Theranostics Market - Spain
  - 9.4.9.1. Spain: Theranostics Market, by Product Type, 2020-2034 (USD Million)
  - 9.4.9.2. Spain: Theranostics Market, by Application, 2020-2034 (USD Million)
  - 9.4.9.3. Spain: Theranostics Market, by Technology, 2020-2034 (USD Million)
  - 9.4.9.4. Spain: Theranostics Market, by End User, 2020-2034 (USD Million)
- 9.4.10. Theranostics Market - Netherlands
  - 9.4.10.1. Netherlands: Theranostics Market, by Product Type, 2020-2034 (USD Million)
  - 9.4.10.2. Netherlands: Theranostics Market, by Application, 2020-2034 (USD Million)
  - 9.4.10.3. Netherlands: Theranostics Market, by Technology, 2020-2034 (USD Million)
  - 9.4.10.4. Netherlands: Theranostics Market, by End User, 2020-2034 (USD Million)
- 9.4.11. Theranostics Market - Russia
  - 9.4.11.1. Russia: Theranostics Market, by Product Type, 2020-2034 (USD Million)
  - 9.4.11.2. Russia: Theranostics Market, by Application, 2020-2034 (USD Million)
  - 9.4.11.3. Russia: Theranostics Market, by Technology, 2020-2034 (USD Million)
  - 9.4.11.4. Russia: Theranostics Market, by End User, 2020-2034 (USD Million)
- 9.4.12. Theranostics Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: Theranostics Market, by Product Type, 2020-2034 (USD Million)
  - 9.4.12.2. Rest of Europe: Theranostics Market, by Application, 2020-2034 (USD Million)
  - 9.4.12.3. Rest of Europe: Theranostics Market, by Technology, 2020-2034 (USD Million)
  - 9.4.12.4. Rest of Europe: Theranostics Market, by End User, 2020-2034 (USD Million)
9.5. Theranostics Market - Asia Pacific
- 9.5.1. Asia Pacific: Theranostics Market, by Product Type, 2020-2034 (USD Million)
- 9.5.2. Asia Pacific: Theranostics Market, by Application, 2020-2034 (USD Million)
- 9.5.3. Asia Pacific: Theranostics Market, by Technology, 2020-2034 (USD Million)
- 9.5.4. Asia Pacific: Theranostics Market, by End User, 2020-2034 (USD Million)
- 9.5.5. Theranostics Market - China
  - 9.5.5.1. China: Theranostics Market, by Product Type, 2020-2034 (USD Million)
  - 9.5.5.2. China: Theranostics Market, by Application, 2020-2034 (USD Million)
  - 9.5.5.3. China: Theranostics Market, by Technology, 2020-2034 (USD Million)
  - 9.5.5.4. China: Theranostics Market, by End User, 2020-2034 (USD Million)
- 9.5.6. Theranostics Market - India
  - 9.5.6.1. India: Theranostics Market, by Product Type, 2020-2034 (USD Million)
  - 9.5.6.2. India: Theranostics Market, by Application, 2020-2034 (USD Million)
  - 9.5.6.3. India: Theranostics Market, by Technology, 2020-2034 (USD Million)
  - 9.5.6.4. India: Theranostics Market, by End User, 2020-2034 (USD Million)
- 9.5.7. Theranostics Market - Malaysia
  - 9.5.7.1. Malaysia: Theranostics Market, by Product Type, 2020-2034 (USD Million)
  - 9.5.7.2. Malaysia: Theranostics Market, by Application, 2020-2034 (USD Million)
  - 9.5.7.3. Malaysia: Theranostics Market, by Technology, 2020-2034 (USD Million)
  - 9.5.7.4. Malaysia: Theranostics Market, by End User, 2020-2034 (USD Million)
- 9.5.8. Theranostics Market - Japan
  - 9.5.8.1. Japan: Theranostics Market, by Product Type, 2020-2034 (USD Million)
  - 9.5.8.2. Japan: Theranostics Market, by Application, 2020-2034 (USD Million)
  - 9.5.8.3. Japan: Theranostics Market, by Technology, 2020-2034 (USD Million)
  - 9.5.8.4. Japan: Theranostics Market, by End User, 2020-2034 (USD Million)
- 9.5.9. Theranostics Market - Indonesia
  - 9.5.9.1. Indonesia: Theranostics Market, by Product Type, 2020-2034 (USD Million)
  - 9.5.9.2. Indonesia: Theranostics Market, by Application, 2020-2034 (USD Million)
  - 9.5.9.3. Indonesia: Theranostics Market, by Technology, 2020-2034 (USD Million)
  - 9.5.9.4. Indonesia: Theranostics Market, by End User, 2020-2034 (USD Million)
- 9.5.10. Theranostics Market - South Korea
  - 9.5.10.1. South Korea: Theranostics Market, by Product Type, 2020-2034 (USD Million)
  - 9.5.10.2. South Korea: Theranostics Market, by Application, 2020-2034 (USD Million)
  - 9.5.10.3. South Korea: Theranostics Market, by Technology, 2020-2034 (USD Million)
  - 9.5.10.4. South Korea: Theranostics Market, by End User, 2020-2034 (USD Million)
- 9.5.11. Theranostics Market - Australia
  - 9.5.11.1. Australia: Theranostics Market, by Product Type, 2020-2034 (USD Million)
  - 9.5.11.2. Australia: Theranostics Market, by Application, 2020-2034 (USD Million)
  - 9.5.11.3. Australia: Theranostics Market, by Technology, 2020-2034 (USD Million)
  - 9.5.11.4. Australia: Theranostics Market, by End User, 2020-2034 (USD Million)
- 9.5.12. Theranostics Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: Theranostics Market, by Product Type, 2020-2034 (USD Million)
  - 9.5.12.2. Rest of Asia Pacific: Theranostics Market, by Application, 2020-2034 (USD Million)
  - 9.5.12.3. Rest of Asia Pacific: Theranostics Market, by Technology, 2020-2034 (USD Million)
  - 9.5.12.4. Rest of Asia Pacific: Theranostics Market, by End User, 2020-2034 (USD Million)
9.6. Theranostics Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Theranostics Market, by Product Type, 2020-2034 (USD Million)
- 9.6.2. Middle East & Africa: Theranostics Market, by Application, 2020-2034 (USD Million)
- 9.6.3. Middle East & Africa: Theranostics Market, by Technology, 2020-2034 (USD Million)
- 9.6.4. Middle East & Africa: Theranostics Market, by End User, 2020-2034 (USD Million)
- 9.6.5. Theranostics Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Theranostics Market, by Product Type, 2020-2034 (USD Million)
  - 9.6.5.2. Saudi Arabia: Theranostics Market, by Application, 2020-2034 (USD Million)
  - 9.6.5.3. Saudi Arabia: Theranostics Market, by Technology, 2020-2034 (USD Million)
  - 9.6.5.4. Saudi Arabia: Theranostics Market, by End User, 2020-2034 (USD Million)
- 9.6.6. Theranostics Market - UAE
  - 9.6.6.1. UAE: Theranostics Market, by Product Type, 2020-2034 (USD Million)
  - 9.6.6.2. UAE: Theranostics Market, by Application, 2020-2034 (USD Million)
  - 9.6.6.3. UAE: Theranostics Market, by Technology, 2020-2034 (USD Million)
  - 9.6.6.4. UAE: Theranostics Market, by End User, 2020-2034 (USD Million)
- 9.6.7. Theranostics Market - Israel
  - 9.6.7.1. Israel: Theranostics Market, by Product Type, 2020-2034 (USD Million)
  - 9.6.7.2. Israel: Theranostics Market, by Application, 2020-2034 (USD Million)
  - 9.6.7.3. Israel: Theranostics Market, by Technology, 2020-2034 (USD Million)
  - 9.6.7.4. Israel: Theranostics Market, by End User, 2020-2034 (USD Million)
- 9.6.8. Theranostics Market - South Africa
  - 9.6.8.1. South Africa: Theranostics Market, by Product Type, 2020-2034 (USD Million)
  - 9.6.8.2. South Africa: Theranostics Market, by Application, 2020-2034 (USD Million)
  - 9.6.8.3. South Africa: Theranostics Market, by Technology, 2020-2034 (USD Million)
  - 9.6.8.4. South Africa: Theranostics Market, by End User, 2020-2034 (USD Million)
- 9.6.9. Theranostics Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: Theranostics Market, by Product Type, 2020-2034 (USD Million)
  - 9.6.9.2. Rest of Middle East & Africa: Theranostics Market, by Application, 2020-2034 (USD Million)
  - 9.6.9.3. Rest of Middle East & Africa: Theranostics Market, by Technology, 2020-2034 (USD Million)
  - 9.6.9.4. Rest of Middle East & Africa: Theranostics Market, by End User, 2020-2034 (USD Million)
9.7. Theranostics Market - Latin America
- 9.7.1. Latin America: Theranostics Market, by Product Type, 2020-2034 (USD Million)
- 9.7.2. Latin America: Theranostics Market, by Application, 2020-2034 (USD Million)
- 9.7.3. Latin America: Theranostics Market, by Technology, 2020-2034 (USD Million)
- 9.7.4. Latin America: Theranostics Market, by End User, 2020-2034 (USD Million)
- 9.7.5. Theranostics Market - Mexico
  - 9.7.5.1. Mexico: Theranostics Market, by Product Type, 2020-2034 (USD Million)
  - 9.7.5.2. Mexico: Theranostics Market, by Application, 2020-2034 (USD Million)
  - 9.7.5.3. Mexico: Theranostics Market, by Technology, 2020-2034 (USD Million)
  - 9.7.5.4. Mexico: Theranostics Market, by End User, 2020-2034 (USD Million)
- 9.7.6. Theranostics Market - Brazil
  - 9.7.6.1. Brazil: Theranostics Market, by Product Type, 2020-2034 (USD Million)
  - 9.7.6.2. Brazil: Theranostics Market, by Application, 2020-2034 (USD Million)
  - 9.7.6.3. Brazil: Theranostics Market, by Technology, 2020-2034 (USD Million)
  - 9.7.6.4. Brazil: Theranostics Market, by End User, 2020-2034 (USD Million)
- 9.7.7. Theranostics Market - Argentina
  - 9.7.7.1. Argentina: Theranostics Market, by Product Type, 2020-2034 (USD Million)
  - 9.7.7.2. Argentina: Theranostics Market, by Application, 2020-2034 (USD Million)
  - 9.7.7.3. Argentina: Theranostics Market, by Technology, 2020-2034 (USD Million)
  - 9.7.7.4. Argentina: Theranostics Market, by End User, 2020-2034 (USD Million)
- 9.7.8. Theranostics Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: Theranostics Market, by Product Type, 2020-2034 (USD Million)
  - 9.7.8.2. Rest of Latin America: Theranostics Market, by Application, 2020-2034 (USD Million)
  - 9.7.8.3. Rest of Latin America: Theranostics Market, by Technology, 2020-2034 (USD Million)
  - 9.7.8.4. Rest of Latin America: Theranostics Market, by End User, 2020-2034 (USD Million)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. F. Hoffmann-La Roche Ltd
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Siemens Healthineers AG
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Thermo Fisher Scientific Inc.
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. GE HealthCare Technologies Inc.
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. Abbott Laboratories
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. Pfizer Inc.
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. Merck KGaA
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. AstraZeneca PLC
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Novartis AG
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Bayer AG
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development